Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 15 June 2004
Vol. 2004, Issue 237, p. pe25
[DOI: 10.1126/stke.2372004pe25]

PERSPECTIVES

CD40: A Growing Cytoplasmic Tale

Margaret M. Harnett

Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow G11 6NT, UK.

Abstract: CD40, a member of the tumor necrosis factor (TNF) receptor family that is expressed on B cells, monocytes, dendritic cells, endothelial cells, and epithelial cells, as well as on B cell lymphomas and carcinomas, activates multiple signaling pathways. In B cells, the response to CD40 is complex and depends on the maturation status of the cell. It is well established that CD40 can promote cell survival through up-regulation of the expression of genes encoding antiapoptotic proteins. However, a new role for CD40 signaling is being recognized in promoting progression through the cell cycle. The roles of the phosphoinositide 3-kinase, mitogen-activated protein kinase, and nuclear factor {kappa}B pathways in mediating CD40 stimulation of the cell cycle are described.

*Corresponding author. E-mail: m.harnett{at}bio.gla.ac.uk

Citation: M. M. Harnett, CD40: A Growing Cytoplasmic Tale. Sci. STKE 2004, pe25 (2004).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma.
T. S. Lewis, R. S. McCormick, K. Emmerton, J. T. Lau, S.-F. Yu, J. A. McEarchern, I. S. Grewal, and C.-L. Law (2011)
Clin. Cancer Res. 17, 4672-4681
   Abstract »    Full Text »    PDF »
TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells.
A. Zirlik, U. Bavendiek, P. Libby, L. MacFarlane, N. Gerdes, J. Jagielska, S. Ernst, M. Aikawa, H. Nakano, E. Tsitsikov, et al. (2007)
Arterioscler Thromb Vasc Biol 27, 1101-1107
   Abstract »    Full Text »    PDF »
c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.
K. T. Lu, F. L. Sinquett, R. L. Dryer, C. Song, and L. R. Covey (2006)
Blood 108, 3769-3776
   Abstract »    Full Text »    PDF »
Key role of the p110{delta} isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110{delta} function in B cells.
A. Bilancio, K. Okkenhaug, M. Camps, J. L. Emery, T. Ruckle, C. Rommel, and B. Vanhaesebroeck (2006)
Blood 107, 642-650
   Abstract »    Full Text »    PDF »
LPS induces CD40 gene expression through the activation of NF-{kappa}B and STAT-1{alpha} in macrophages and microglia.
H. Qin, C. A. Wilson, S. J. Lee, X. Zhao, and E. N. Benveniste (2005)
Blood 106, 3114-3122
   Abstract »    Full Text »    PDF »
Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40.
C.-L. Law, K. A. Gordon, J. Collier, K. Klussman, J. A. McEarchern, C. G. Cerveny, B. J. Mixan, W. P. Lee, Z. Lin, P. Valdez, et al. (2005)
Cancer Res. 65, 8331-8338
   Abstract »    Full Text »    PDF »
Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance.
B. Huang, J. Zhao, H. Li, K.-L. He, Y. Chen, L. Mayer, J. C. Unkeless, and H. Xiong (2005)
Cancer Res. 65, 5009-5014
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882